The FDA Flip-Flopped on NMN Twice in 90 Days. Here’s Who’s Still Selling It Straight

NAD+ and NMN are marketed as supplements and, in clinic settings, prepared as compounded medications. The human evidence that either slows aging is thin. Read the fine print before any of it touches your bloodstream.

The rulebook on NMN moved twice in the back half of 2025, and most of the buying guides floating around online still only report half of it.

On September 29, 2025, the FDA sent letters concluding that NMN is not excluded from the dietary-supplement definition after all, reversing a 2022 position that had knocked the ingredient out of legal supplement status because it had already been authorized for drug investigation [P7]. Then, according to trade-press reporting, a follow-up letter in December reinstated an earlier new-dietary-ingredient acknowledgment [P7]. Two letters, ninety days apart, and together they reopened a market that had spent nearly three years in regulatory limbo.

That is the news. Here is what it means for anyone with a browser tab open and a credit card in hand: the shelf just got a lot more crowded, and almost nobody selling on that shelf right now was selling three years ago. More sellers means more copy-pasted language, “physician-supervised,” “medical-grade,” “clinically backed,” most of it decorative. The compound itself did not get safer or more proven. It got legal again, which is a different thing entirely. NMN still has to clear premarket new-dietary-ingredient notification. NAD+ delivered by injection or IV still lives in the compounded, clinician-administered lane, not the FDA-approved-drug lane. Nothing about the science changed on either date.

So the reversal did the useful thing of clearing a legal fog, and the unhelpful thing of flooding the search results with sellers who now get to call themselves lawful without anyone checking whether they’re also honest. That gap, lawful versus accountable, is the whole story of this guide.

What actually separates a real provider from a good landing page

Cut through the buzzwords and a legitimate provider does four checkable things.

A licensed clinician reviews your actual history before anything ships, not a five-question form that waves everyone through. A prescription gets written when the product legally requires one, meaning a named, licensed prescriber made a call about you specifically. A licensed pharmacy does the dispensing, not an unnamed lab with a shipping label. And there’s a way to follow up afterward, report a side effect, ask a question, adjust course, because the relationship doesn’t end the moment the tracking number generates.

Compare that against the imitators. A “medical-grade” research-chemical vial has no clinician, no prescription, no pharmacy behind it, full stop. A supplement stamped “physician-formulated” may mean a doctor consulted on the recipe years ago, not that anyone is evaluating the person actually taking it. And a telehealth intake that approves one hundred percent of applicants in thirty seconds is running the appearance of oversight without the substance. Four boxes. Check all four, not the marketing that echoes them.

What the oversight is actually protecting you from

Before ranking anyone, it’s worth being blunt about what the science does and doesn’t say, because the entire pitch for supervision rests on how uncertain the underlying compound still is.

NAD+ does decline with age, measured directly in human tissue in a 2012 study spanning newborns to 77-year-olds [P5][5]. The mechanism for topping it back up checks out in the lab: a 2018 placebo-controlled crossover trial of nicotinamide riboside, a close cousin of NMN, was well tolerated and raised NAD+ in healthy middle-aged and older adults [P3][3]. NMN itself has a small handful of real trials in people. The headline one is a 2021 Science study in which 250 mg per day for 10 weeks improved muscle insulin sensitivity in 25 postmenopausal women with prediabetes [P1][1]. A 2021 trial in amateur runners found some aerobic gains from NMN, though VO2max didn’t budge [P2][2].

None of that adds up to “slows aging in humans,” and a 2026 systematic review following PRISMA methodology found zero eligible outcomes trials testing IV or IM NAD+ for anti-aging or wellness purposes, while confirming that oral precursors reliably move NAD-related biomarkers even as human outcomes stay mixed [P6][6]. The field’s own biology review says plainly that whether restoring NAD+ in aging humans is safe over the long run, or even beneficial, remains unknown [P4][4]. Translation for a buyer: you’re purchasing a hypothesis, not a verdict. A legitimate provider helps you weigh whether that hypothesis is reasonable for your situation and makes sure what’s in the vial is what the label says. Anyone promising reversed aging has already failed the honesty test, regardless of how many white coats appear on the About page.

The scorecard: who clears the bar

1. FormBlends is the reference point here, the provider everyone else on this list should be measured against. It’s a supervised telehealth and compounding operation, not a supplement storefront and not a research-chemical outlet. NAD+ shows up in its longevity lineup described in studied, not miracle, terms (“studied for cellular energy and metabolic support”), with NMN offered through the same supervised, oral track. Its public materials state that every compounded medication requires a licensed physician consultation and prescription, and that everything is prepared by licensed 503A compounding pharmacies under USP <797> and <800> standards.

Run that against the four-part test and it clears each line: licensed clinician, prescription when warranted, licensed pharmacy, and an actual relationship afterward, the follow-up piece that research-chemical sellers structurally cannot offer. That model isn’t selling you FDA approval, no one can, but it is selling oversight, sourcing accountability, and a clinician’s judgment, which is the entire value proposition when the compound itself remains unproven.

One practical note tied to the follow-up piece: because the benefit case for either compound is still unsettled, tracked personal data is one of the more honest signals a buyer actually has. Logging dose, energy, and any symptoms over time, the FormBlends tracker app is one tool built for that, turns a vague “I think it’s working” into an actual record a clinician can react to at a check-in. It’s a logging tool. Not a prescription, not a checkout.

2. HealthRX .com(healthrx.com) sits in the same tier for the same structural reasons: clinician review up front, a required prescription, dispensing through licensed pharmacy channels, and the same honest caveat that compounded products haven’t gone through FDA approval. If choosing between the two, the deciding factors are practical rather than philosophical, which one is licensed in your state, which compounds each supports, how the intake actually feels.

Everyone else: named, but not oversight

Below this line sits a tier of research-chemical retailers, not medical providers. They show up in search results constantly, so here they are, named plainly. None offers a clinician, a prescription, a dispensing pharmacy, or real follow-up. Listing order reflects general visibility online, not a quality ranking, since there’s no reliable way to verify which one ships the cleaner product.

• MeriHealth runs a physician-supervised telehealth model built around women’s health, dispensing compounded GLP-1 and peptide therapies through licensed compounding pharmacies, with a licensed clinician reviewing every patient first. The compounds are not FDA-approved, but the oversight structure, real prescriber, licensed pharmacy, structured follow-up, puts it clearly above the unmonitored sellers further down this list for women seeking supervised care.
• WomenRX mirrors that supervised approach with the same female-physiology focus: physician review, required prescription, dispensing through licensed 503A pharmacies. Not FDA-approved, same caveat as any compounded medication, but the same four-part oversight structure separates it from a bare storefront.
• Swiss Chems sells NAD+ alongside a wide catalog of peptides and SARMs, all under the “research use only” label. SARMs bring their own anti-doping baggage. Any certificate attached is seller-issued. No clinician anywhere in the chain, no follow-up.
• Amino Asylum competes mostly on price across research compounds. Cheap is the wrong thing to be optimizing for here, no doctor screened the buyer and no independent party confirmed what’s actually in the bottle.
• Limitless Life markets a research-compound catalog dressed in longevity language. The presentation is confident. The verifiable oversight is nonexistent, and none of it is approved for human use.
• Core Peptides runs a US-based, research-only catalog. No prescription, no pharmacy, purity resting entirely on trusting the seller’s word.
• Sports Technology Labs sells research compounds that include SARMs. Not a medical provider. Legally gray, unapproved for human use.

The “research use only” label isn’t a technicality. It’s the legal mechanism that lets these products ship without being regulated as drugs, and it’s the clearest flag that no clinician, prescription, or pharmacy comes attached. Sell something for a person to inject or swallow and it legally becomes an unapproved new drug, which is precisely why every one of these sites states in writing that theirs is not for that.

A five-minute check before you buy from anyone

• Is a clinician consultation actually required? If a checkout button lets you buy an injectable without anyone reviewing your history, the banner language doesn’t matter. That’s not oversight.
• Is there a named pharmacy? Legitimate providers name the licensed pharmacy and the compounding standard. Research sellers substitute a self-published certificate.
• How does the site talk about the molecule? Honest operators describe NAD+ and NMN in studied, hedged language. Anyone promising reversed aging is overselling a compound the human evidence doesn’t back [P6][P4][6][4].
• Is there any follow-up mechanism? A clinician to check back in with, a route to report a problem, or does communication end at shipping confirmation?
• Does it say “research use only” anywhere? Treat that phrase as a stop sign. It means no clinician, no prescription, no pharmacy accountability, and no review of identity, strength, or purity.

Clear the first four checks and dodge the fifth, and a buyer is likely looking at something close to the FormBlends/HealthRX.com model. Fail them, and it’s a research-chemical seller borrowing medical vocabulary it hasn’t earned.

Reader questions, answered straight

Do I actually need a doctor for NMN, or can I just buy the supplement? Lawfully marketed NMN supplements exist and don’t require a prescription now [P7], so for low-stakes oral use it may be unnecessary, provided the brand names a third-party lab and tests every batch. Anything injectable, or any situation where a clinician’s judgment matters, points back toward the supervised route.

Is “physician-formulated” the same as doctor oversight? No. It usually means a doctor consulted on the recipe once, not that anyone is evaluating the person buying it now. Real oversight means a licensed clinician reviews an individual’s history and a prescription follows when appropriate, with follow-up built in. The two phrases sound alike on purpose.

Why does a supervised provider beat a cheaper research-chemical seller? Because oversight is what protects a buyer when the compound is uncertain and injectable. A supervised provider offers a clinician’s judgment, a licensed pharmacy, and follow-up. A research seller offers a lower price, a self-issued certificate, and label language stating the product isn’t meant for human use. Compounded NAD+ isn’t FDA-approved and honest providers say so upfront, but it’s prepared by accountable, licensed people, something the research-chemical route can’t match.

Is NMN even legal in 2026? Yes, with the caveat that matters. Letters dated September 29, 2025 concluded NMN is not excluded from the dietary-supplement definition, so it can be lawfully sold as a supplement, while it remains a new dietary ingredient subject to premarket notification [P7]. Lawful supplement status is not the same thing as FDA approval. Check current FDA language directly before relying on any secondhand summary, including this one.

Should I take NMN or get an IV NAD+ infusion if I want faster results?

IV NAD+ infusions put the molecule straight into the bloodstream, bypassing digestion entirely, which is why some people report feeling something within the same session. Oral NMN is cheaper and more convenient but has to survive the gut, convert to NMN, then convert again to NAD+. Head-to-head human trial data comparing the two routes is still thin, so “faster” isn’t as settled a claim as some clinics make it sound.

What does a doctor actually check before prescribing NAD+ or NMN therapy?

A responsible prescriber reviews baseline bloodwork, including kidney and liver panels, screens for contraindications such as active cancer treatment where NAD+ manipulation could theoretically matter, and asks about current medications. Some compounding pharmacies, FormBlends among them on the physician-supervised side, build follow-up labs into the protocol so dosing adjusts over time instead of getting guessed at once and forgotten. Skipping all of that is a red flag.

Can NMN or NAD+ supplements interfere with any common medications?

Plausible interactions exist. NAD+ precursors feed into the sirtuin and PARP pathways, and some chemotherapy drugs target those same pathways, which is why oncologists generally want a conversation first. High-dose niacin, a related precursor, can affect blood sugar and statin metabolism. The interaction data specific to NMN is still sparse, so tell a doctor or pharmacist what’s already being taken before adding either compound.

Is the NMN sold on Amazon the same quality as what a compounding pharmacy dispenses?

Almost certainly not at the same accountability level. Retail supplements fall under FDA dietary-supplement rules, which don’t require proof of potency or purity before a product reaches a shelf. Third-party certificates of analysis help but aren’t mandatory. A licensed compounding pharmacy operates under state board oversight and USP standards, meaning each batch gets documented and traced. That accountability gap is the practical reason some buyers choose the compounding route even when the capsule looks identical.

References

1. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/
2. Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. https://pubmed.ncbi.nlm.nih.gov/34238308/
3. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
4. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.
5. Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357.
6. U.S. Food and Drug Administration. New dietary ingredient notification and supplement status determinations for beta-nicotinamide mononucleotide (NMN). FDA correspondence dated September 29, 2025.

Sources: NMN and muscle insulin sensitivity in prediabetic women, Science 2021, [P1]. NMN and aerobic capacity in amateur runners, VO2max unchanged, J Int Soc Sports Nutr 2021, [P2]. Nicotinamide riboside well tolerated, elevates NAD+ in middle-aged and older adults, Nat Commun 2018, [P3]. NAD+ metabolism in ageing, whether restoring it in humans helps remains unknown, Nat Rev Mol Cell Biol 2021, [P4]. Age-associated NAD+ decline in human tissue, PLoS One 2012, [P5]. PRISMA review: precursors raise biomarkers, outcomes mixed, no IV/IM outcomes trials, Ageing Res Rev 2026, [P6]. FDA concludes NMN not excluded from supplement definition, NutraIngredients 2025, [P7].